UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000040166 |
|---|---|
| Receipt number | R000045160 |
| Scientific Title | Study on mobilization of Muse cells in patients with heart disease |
| Date of disclosure of the study information | 2020/05/01 |
| Last modified on | 2025/10/19 14:09:11 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study on mobilization of Muse cells in patients with heart disease
Acronym
Study on mobilization of Muse cells in patients with heart disease
Scientific Title
Study on mobilization of Muse cells in patients with heart disease
Scientific Title:Acronym
Study on mobilization of Muse cells in patients with heart disease
Region
| Japan |
Condition
Condition
heart disease
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To measure the number of Muse cells in patients with heart disease
Basic objectives2
Others
Basic objectives -Others
Assessment of Muse cells mobilization in patients with heart disease
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The number of Muse cells in the peripheral blood in patients with heart disease
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 90 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
heart disease (coronary artery disease, dilated cardiomyopathy, valvular heart disease, atrial fibrillation)
Key exclusion criteria
patients whom doctor considered inappropriate
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Shinya |
| Middle name | |
| Last name | Minatoguchi |
Organization
Gifu University
Division name
Department of Circulatory and Respiratory Advanced MedicineGraduate School of Medicine,
Zip code
5011194
Address
1-1 Yanagido, Gifu city, Gifu
TEL
0582306523
minatos@gifu-u.ac.jp
Public contact
Name of contact person
| 1st name | Shinya |
| Middle name | |
| Last name | Minatoguchi |
Organization
Gifu University
Division name
Department of Circulatory and Respiratory Advanced Medicine, Graduate School of Medicine
Zip code
5011194
Address
1-1 Yanagido, Gifu city, Gifu
TEL
0582306523
Homepage URL
minatos@gifu-u.ac.jp
Sponsor or person
Institute
Gifu University
Institute
Department
Personal name
Funding Source
Organization
Gifu University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Gifu University
Address
1-1 Yanagido, Gifu city, Gifu
Tel
0582306523
minatos@gifu-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 05 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
18
Results
The number of Muse cells increased 24 hour after PCI.
Results date posted
| 2025 | Year | 10 | Month | 19 | Day |
Results Delayed
| Delay expected |
Results Delay Reason
We submitted but rejected.
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2016 | Year | 03 | Month | 16 | Day |
Date of IRB
| 2016 | Year | 03 | Month | 16 | Day |
Anticipated trial start date
| 2016 | Year | 03 | Month | 16 | Day |
Last follow-up date
| 2024 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We aim to measure the number of Muse cells in the peripheral blood in vcardiac patients.
Management information
Registered date
| 2020 | Year | 04 | Month | 15 | Day |
Last modified on
| 2025 | Year | 10 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045160
